Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2025)
Verastem's (VSTM) quarterly Depreciation & Amortization (CF) came in at $18000.0 in Q4 2025, up 157.14% year-on-year from $7000.0 in Q4 2024, and up 800.0% quarter-over-quarter from $2000.0 in Q3 2025.
Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Verastem's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 157.14% year-over-year to $18000.0 in Q4 2025; TTM through Mar 2026 was $20000.0, a 31.03% decrease from a year earlier, with the FY2025 full-year figure at $30000.0, up 15.38% from the prior year.
- Depreciation & Amortization (CF) advanced to $18000.0 in Q4 2025 per VSTM's latest filing, from $2000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $81000.0 in Q1 2021 and bottomed at $2000.0 in Q3 2025.
- The 5-year median for Depreciation & Amortization (CF) is $22000.0 (2023), against an average of $23210.5.
- Across the five-year window, Depreciation & Amortization (CF) sank 88.51% in 2021 and jumped 157.14% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $30000.0 in 2021, then retreated by 3.33% to $29000.0 in 2022, then slumped by 82.76% to $5000.0 in 2023, then surged by 40.0% to $7000.0 in 2024, then soared by 157.14% to $18000.0 in 2025.
- Per Business Quant, the three latest VSTM Depreciation & Amortization (CF) figures stand at $18000.0 (Q4 2025), $2000.0 (Q3 2025), and $10000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |